Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis

• 主要な著者: Masoud Etemadifar (著者), Amir Parsa Abhari (著者), Hosein Nouri (著者), Amirhossein Akhavan Sigari (著者), Seyed Mohammad Piran Daliyeh (著者), Mohammad Reza Maracy (著者), Mehri Salari (著者), Shiva Maleki (著者), Nahad Sedaghat (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among people with multiple sclerosis (pwMS), 517 vaccinated and 174 unvaccinated pwMS were interviewed. 16.2% of the vaccinated pwMS reported at least one neurological symptom in their respective vaccine-related at-risk p...